Adams Diversified Equity Fund’s Merck MRK Stock Holding History

Adams Diversified Equity Fund’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.7M	Sell	270,300 -29,900	-10%	-$3.5M	1.06%	24
2026 Q1	$36.1M	Sell	300,200 -8,600	-3%	-$993K	1.27%	18
2025 Q4	$32.5M	Hold	308,800	–	–	1.08%	22
2025 Q3	$25.9M	Buy	+308,800	New	+$25.4M	0.87%	30
2024 Q4	–	Sell	-86,400	Closed	-$9.81M	–	103
2024 Q3	$9.81M	Hold	86,400	–	–	0.36%	88
2024 Q2	$10.7M	Hold	86,400	–	–	0.36%	86
2024 Q1	$11.4M	Sell	86,400 -246,300	-74%	-$30.4M	0.4%	82
2023 Q4	$36.3M	Hold	332,700	–	–	1.43%	16
2023 Q3	$34.3M	Buy	332,700 +109,400	+49%	+$11.8M	1.46%	14
2023 Q2	$25.8M	Buy	223,300 +139,300	+166%	+$15.8M	1.07%	27
2023 Q1	$8.94M	Hold	84,000	–	–	0.4%	91
2022 Q4	$9.32M	Buy	+84,000	New	+$8.59M	0.45%	85
2021 Q1	–	Sell	-87,194	Closed	-$6.81M	–	115
2020 Q4	$6.81M	Sell	87,194 -24,732	-22%	-$1.89M	0.31%	95
2020 Q3	$8.86M	Sell	111,926 -79,229	-41%	-$6.21M	0.43%	82
2020 Q2	$14.1M	Sell	191,155 -112,031	-37%	-$8.43M	0.75%	53
2020 Q1	$22.3M	Sell	303,186 -125,132	-29%	-$9.83M	1.41%	18
2019 Q4	$37.2M	Hold	428,318	–	–	1.91%	8
2019 Q3	$34.4M	Hold	428,318	–	–	1.83%	10
2019 Q2	$34.3M	Sell	428,318 -34,164	-7%	-$2.62M	1.82%	9
2019 Q1	$36.7M	Hold	462,482	–	–	2.02%	5
2018 Q4	$33.7M	Sell	462,482 -41,606	-8%	-$2.94M	2.08%	7
2018 Q3	$34.1M	Buy	504,088 +100,189	+25%	+$6.38M	1.69%	15
2018 Q2	$23.4M	Buy	+403,899	New	+$22.8M	1.25%	28
2017 Q2	–	Sell	-368,372	Closed	-$22.3M	–	216
2017 Q1	$22.3M	Hold	368,372	–	–	1.28%	26
2016 Q4	$20.7M	Sell	368,372 -134,668	-27%	-$7.88M	1.28%	29
2016 Q3	$27.7M	Hold	503,040	–	–	1.86%	14
2016 Q2	$27.7M	Hold	503,040	–	–	1.86%	14
2016 Q1	$25.4M	Hold	503,040	–	–	1.77%	16
2015 Q4	$25.4M	Hold	503,040	–	–	1.74%	17
2015 Q3	$23.7M	Hold	503,040	–	–	1.71%	20
2015 Q2	$27.3M	Hold	503,040	–	–	1.8%	15
2015 Q1	$27.6M	Hold	503,040	–	–	1.82%	14
2014 Q4	$27.3M	Hold	503,040	–	–	1.8%	14
2014 Q3	$28.5M	Hold	503,040	–	–	1.88%	12
2014 Q2	$27.8M	Hold	503,040	–	–	1.85%	11
2014 Q1	$27.3M	Hold	503,040	–	–	1.92%	11
2013 Q4	$24M	Sell	503,040 -20,960	-4%	-$958K	1.7%	15
2013 Q3	$23.8M	Hold	524,000	–	–	1.81%	15
2013 Q2	$23.2M	Buy	+524,000	New	+$23.4M	1.85%	12

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Adams Diversified Equity Fund's MRK Position: Q2 2026 in Review

Adams Diversified Equity Fund reduced its Merck (MRK) stake by 10% in Q2 2026, selling an estimated $3.5M and leaving 270,300 shares worth $34.7M. The position accounts for 1.06% of the portfolio, ranked #24.

Adams Diversified Equity Fund first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. The position peaked at $37.2M in Q4 2019. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Adams Diversified Equity Fund held 270,300 shares of Merck worth $34.7M as of Q2 2026.
Adams Diversified Equity Fund sold 29,900 Merck shares in Q2 2026, an estimated $3.5M.
Merck made up 1.06% of Adams Diversified Equity Fund's portfolio in Q2 2026, its #24 holding.
Adams Diversified Equity Fund first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
Adams Diversified Equity Fund's Merck position peaked at $37.2M in Q4 2019.
1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2026, filed 22 Jul 2026.